okn-007
Small moleculeexperimental
Clinical trial activity
6 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2012 (NCT01672463)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- okn007
- okn 007
- okn-007
- okn-007
- okn-007
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05561374 | Phase 1 | Nov 29, 2022 | Oblato, Inc. |
| NCT04388475 | Phase 2 | May 25, 2020 | Oblato, Inc. |
| NCT03649464 | Phase 1/Phase 2 (Phase 2) | Apr 30, 2019 | Oblato, Inc. |
| NCT03587038 | Phase 1 | Sep 3, 2018 | University of Oklahoma |
| NCT01672463 | Phase 1 | Dec 1, 2012 | Oblato, Inc. |
| NCT05518838 | N/A | — | Oblato, Inc. |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Oblato, Inc. | For profit | 5 | 5 | 3 | 2012 |
| University of Oklahoma | Academic/Hospital | 1 | 1 | 1 | 2018 |
2 organizations
Page 1 / 1